C Diff Treatment

C Diff Treatment

1249 bookmarks
Custom sorting
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
Centralized case identification and in-home enrollment is a feasible and innovative method of conducting randomized controlled trials in the Veterans Affairs system, improving access to clinical research for populations who may have difficulty engaging with the traditional model of clinical trials w …
·pubmed.ncbi.nlm.nih.gov·
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
JULY 16, 2021 Patient, Family, Caregiver Symposium | C Diff Foundation
JULY 16, 2021 Patient, Family, Caregiver Symposium | C Diff Foundation
JULY 2021:  C. diff. Patient, Family, and Caregiver  Live-Online Symposium from 1:00 p.m. – 3:00 p.m. EDT           Intended Audience:  Patients Diagnosed With a C. d…
·cdifffoundation.org·
JULY 16, 2021 Patient, Family, Caregiver Symposium | C Diff Foundation
What Are Treatment Options for C. diff? - Pharmacy Times
What Are Treatment Options for C. diff? - Pharmacy Times
Pharmacists should educate themselves about the options available to help patients manage this bacterium that causes severe diarrhea and colitis.
·pharmacytimes.com·
What Are Treatment Options for C. diff? - Pharmacy Times
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients - Healio
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients - Healio
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant and hematopoietic-cell transplant recipients, according to a study published in Open Forum Infectious Diseases.“Solid-organ and hematopoietic-cell transplant recipients are at high-risk for recurrent Clostridioides difficile infection and poor outcomes associated
·healio.com·
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients - Healio
ACG issues guidelines for C. diff management in adults
ACG issues guidelines for C. diff management in adults
In clinical guidelines issued by the American College of Gastroenterology and published online May 19 in the American Journal of Gastroenterology, recommendations are presented for the management of Clostridioides ...
·medicalxpress.com·
ACG issues guidelines for C. diff management in adults
Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile
Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile
Clostridioides difficile is a leading health threat. This pathogen initiates intestinal infections during gut microbiota dysbiosis caused by oral administration of antibiotics. C. difficile is difficult to eradicate due to its ability to form spores, which are not susceptible to antibi …
·pubmed.ncbi.nlm.nih.gov·
Structure-Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile
The Integrity of Heme Is Essential For Reproducible Detection of Metronidazole-Resistant Clostridioides difficile By Agar Dilution Susceptibility Tests
The Integrity of Heme Is Essential For Reproducible Detection of Metronidazole-Resistant Clostridioides difficile By Agar Dilution Susceptibility Tests
Metronidazole resistance in clinical Clostridioides difficile is often described as unstable, since resistant strains reportedly appear susceptible following freezer storage or brief passage. This has presented a conundrum for adopting susceptibility testing to accurately evaluate the connect …
·pubmed.ncbi.nlm.nih.gov·
The Integrity of Heme Is Essential For Reproducible Detection of Metronidazole-Resistant Clostridioides difficile By Agar Dilution Susceptibility Tests
Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018
Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018
IntroductionThe contribution of healthcare-associated infections (HAI) to mortality can be estimated using statistical methods, but mortality review (MR) is better suited for routine use in clinical settings. The European Centre for Disease Prevention and Control recently introduced MR into its HAI …
·pubmed.ncbi.nlm.nih.gov·
Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
Articles, guidelines, presentations, webcasts and directives from our scientists and partners in the field of clinical microbiology and infectious diseases.
·escmid.org·
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
Cancer-related diarrhea often leads to treatment discontinuation
Cancer-related diarrhea often leads to treatment discontinuation
Patients with cancer-related diarrhea appeared 40% more likely than those without the condition to discontinue index therapy, according to retrospective study results presented during the virtual ASCO Annual Meeting.Cancer-related diarrhea also prompted earlier switches to alternate regimens and additional health care utilization, results showed.
·healio.com·
Cancer-related diarrhea often leads to treatment discontinuation
Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection
Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection
Incidence of Clostridioides difficile infection (CDI) has been increasing in recent decades due to different factors, namely (i) extended use of broad-spectrum antibiotics, (ii) transmission within asymptomatic and susceptible patients, and (iii) unbalanced gastrointestinal microbiome and col …
·pubmed.ncbi.nlm.nih.gov·
Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection
Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics-An Option for Diarrhea Management in Nursing Facilities
Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics-An Option for Diarrhea Management in Nursing Facilities
Diarrhea is a common problem in nursing homes. A survey among nursing facilities in Poland was used to characterize diarrhea outbreaks, the burden caused for residents and caregivers and the employed measures. Survey results confirmed that diarrhea is a common problem in nursing homes and in most ca …
·pubmed.ncbi.nlm.nih.gov·
Inhibition of Quinolone- and Multi-Drug-Resistant Clostridioides Difficile Strains by Multi Strain Synbiotics-An Option for Diarrhea Management in Nursing Facilities
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
In this study, we report the results of the epidemiological analysis of Clostridioides difficile ribotypes (RTs) and antimicrobial susceptibility testing. Most isolates were RT027, representing 73% (84/115) of isolates. No isolates with reduced susceptibility to fidaxomicin were found; howeve …
·pubmed.ncbi.nlm.nih.gov·
Diversity of Circulating Clostridioides difficile Ribotypes in Mexico and Susceptibility to Fidaxomicin, Vancomycin, and Metronidazole
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease
Hospitalization for inflammatory bowel disease is common and requires coordination of care. The goals of hospitalization are to markedly improve symptoms, transition management to an outpatient regimen, and prevent complications. Initially, providers should determine the phenotype and severity of di …
·pubmed.ncbi.nlm.nih.gov·
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease
Effects of vancomycin on persistent pain-stimulated and pain-depressed behaviors in female Fischer rats with or without voluntary access to running wheels - PubMed
Effects of vancomycin on persistent pain-stimulated and pain-depressed behaviors in female Fischer rats with or without voluntary access to running wheels - PubMed
The present experiments determined the effects of the narrow-spectrum antibiotic vancomycin on inflammatory pain-stimulated and pain-depressed behaviors in rats. Persistent inflammatory pain was modeled using dilute formalin (0.5%). Two weeks of oral vancomycin administered in drinking water attenua …
·pubmed.ncbi.nlm.nih.gov·
Effects of vancomycin on persistent pain-stimulated and pain-depressed behaviors in female Fischer rats with or without voluntary access to running wheels - PubMed